Sold
Available
IBL-26-0412

Composition for inducing neuroectodermal differentiation of stem cells

Listed on
2026-07-03
Stem Cell Neuroectodermal Differentiation-Inducing Composition Comprising MMP Inhibitors

This technology provides a composition for inducing neuroectodermal differentiation of stem cells, comprising a TGF-β receptor ALK5 inhibitor, a BMP inhibitor, and an MMP inhibitor.

There was a need for a method to efficiently differentiate stem cells into specific cells for cell therapy.

This technology enhances differentiation efficiency by treating human embryonic and induced pluripotent stem cells with three types of inhibitors, which promotes neuroectodermal differentiation.

Key Features:
  • Contains TGF-β receptor ALK5 inhibitor
  • Contains BMP inhibitor
  • Contains MMP (Matrix Metalloproteinase) inhibitor
  • Improved neuroectodermal differentiation efficiency in human stem cells
Pohang University of Science & Technology
Jang Jiwon | Yang Seungbok
Document
Date of application:
2022-04-13
|
Patent registration number:
10-2772848
Industry
bio
Technology
Bio/Pharmaceutical
Country
Korea
Family Patent

N/A

Price
가격협의
Subscribe to our newsletter to receive the latest patent information faster than anyone else.
← Back to list